TY - JOUR
T1 - Preprocedural restoration of sinus rhythm and left atrial strain predict outcomes of catheter ablation for long-standing persistent atrial fibrillation
AU - Hanaki, Yuichi
AU - Machino-Ohtsuka, Tomoko
AU - Aonuma, Kazutaka
AU - Komatsu, Yuki
AU - Machino, Takeshi
AU - Yamasaki, Hiro
AU - Igarashi, Miyako
AU - Sekiguchi, Yukio
AU - Nogami, Akihiko
AU - Ieda, Masaki
N1 - Publisher Copyright:
© 2020 Wiley Periodicals LLC
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Introduction: Catheter ablation (CA) for long-standing persistent atrial fibrillation (LS-AF) remains challenging. We aimed to explore whether sinus rhythm (SR) restoration and left atrium (LA) function after pretreatment with antiarrhythmic drugs (AAD's) and electrical cardioversion (ECV) predict procedural outcomes. Methods and Results: We included 100 consecutive patients with LS-AF who were treated with AAD/ECV for at least 3 months before CA. The echocardiographic LA strain during reservoir phase (LASr) was assessed after pretreatment as a marker of LA fibrosis. The recurrence was recorded for ≥1 year after the last procedure. During a 34 ± 16-month follow-up period, the single and multiple procedures and pharmaceutically assisted success rates were 40% and 71%, respectively. Patients with preprocedural SR restoration and higher LASr showed a significantly higher recurrence-free probability after the last CA (logrank P =.001 and P <.001, respectively). Failure of preprocedural SR restoration and LASr ≤8.6% were independently associated with recurrence after the last CA (hazard ratio [HR]: 3.13, 95% confidence interval [CI]: 1.42-6.91, P =.005; HR: 3.89, 95% CI: 1.65-9.17, P =.002, respectively). These parameters added incrementally to the predictive value of AF duration and LA dilatation (P =.03 and P =.002, respectively) and improved the recurrence-risk stratification (net reclassification improvement = 0.39; 95% CI = 0.13-0.65; P =.003). Conclusion: In patients with LS-AF, the inability to restore SR and lower LASr after AAD/ECV treatment independently and incrementally predicts the recurrence after CA. These findings might be useful for determining LS-AF ablation candidates.
AB - Introduction: Catheter ablation (CA) for long-standing persistent atrial fibrillation (LS-AF) remains challenging. We aimed to explore whether sinus rhythm (SR) restoration and left atrium (LA) function after pretreatment with antiarrhythmic drugs (AAD's) and electrical cardioversion (ECV) predict procedural outcomes. Methods and Results: We included 100 consecutive patients with LS-AF who were treated with AAD/ECV for at least 3 months before CA. The echocardiographic LA strain during reservoir phase (LASr) was assessed after pretreatment as a marker of LA fibrosis. The recurrence was recorded for ≥1 year after the last procedure. During a 34 ± 16-month follow-up period, the single and multiple procedures and pharmaceutically assisted success rates were 40% and 71%, respectively. Patients with preprocedural SR restoration and higher LASr showed a significantly higher recurrence-free probability after the last CA (logrank P =.001 and P <.001, respectively). Failure of preprocedural SR restoration and LASr ≤8.6% were independently associated with recurrence after the last CA (hazard ratio [HR]: 3.13, 95% confidence interval [CI]: 1.42-6.91, P =.005; HR: 3.89, 95% CI: 1.65-9.17, P =.002, respectively). These parameters added incrementally to the predictive value of AF duration and LA dilatation (P =.03 and P =.002, respectively) and improved the recurrence-risk stratification (net reclassification improvement = 0.39; 95% CI = 0.13-0.65; P =.003). Conclusion: In patients with LS-AF, the inability to restore SR and lower LASr after AAD/ECV treatment independently and incrementally predicts the recurrence after CA. These findings might be useful for determining LS-AF ablation candidates.
KW - antiarrhythmic drugs
KW - catheter ablation
KW - electrical cardioversion
KW - left atrial strain
KW - long-standing persistent atrial fibrillation
UR - https://www.scopus.com/pages/publications/85084634813
UR - https://www.scopus.com/pages/publications/85084634813#tab=citedBy
U2 - 10.1111/jce.14540
DO - 10.1111/jce.14540
M3 - Article
C2 - 32391641
AN - SCOPUS:85084634813
SN - 1045-3873
VL - 31
SP - 1709
EP - 1718
JO - Journal of Cardiovascular Electrophysiology
JF - Journal of Cardiovascular Electrophysiology
IS - 7
ER -